Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Satoshi Igawa, Masashi Kasajima, Taihei Ono, Takahiro Ozawa, Mikiko Kakegawa, Seiichiro Kusuhara, Takashi Sato, Yoshiro Nakahara, Tomoya Fukui, Masanori Yokoba, Masaru Kubota, Hisashi Mitsufuji, Jiichiro Sasaki & Katsuhiko Naoki. (2021) A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer. Cancer Management and Research 13, pages 8695-8705.
Read now
Read now
Paola C. Sacco, Paolo Maione, Giovanni Palazzolo & Cesare Gridelli. (2018) Treatment of advanced non-small cell lung cancer in the elderly. Expert Review of Respiratory Medicine 12:9, pages 783-792.
Read now
Read now
Hiroshi Isobe, Kiyoshi Mori, Koichi Minato, Hideki Katsura, Kazuko Taniguchi, Ashwini Arunachalam, Smita Kothari, Xiting Cao & Terufumi Kato. (2017) Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan. Lung Cancer: Targets and Therapy 8, pages 191-206.
Read now
Read now
Tania Losanno & Cesare Gridelli. (2017) Recent advances in targeted advanced lung cancer therapy in the elderly. Expert Review of Anticancer Therapy 17:9, pages 787-797.
Read now
Read now
Articles from other publishers (20)
Yoshihiko Sakata, Go Saito, Shinya Sakata, Yuko Oya, Motohiro Tamiya, Hidekazu Suzuki, Ryota Shibaki, Asuka Okada, Toshihide Yokoyama, Hirotaka Matsumoto, Taiichiro Otsuki, Yuki Sato, Uchida Junji, Yoko Tsukita, Megumi Inaba, Hideki Ikeda, Daisuke Arai, Hirotaka Maruyama, Satoshi Hara, Shinsuke Tsumura, Jun Morinaga & Takuro Sakagami. (2023) Osimertinib as first-line treatment for elderly patients with advanced EGFR mutation-positive non-small cell lung cancer in a real-world setting (OSI-FACT-EP). Lung Cancer 186, pages 107426.
Crossref
Crossref
Wei Chen, Julian Miao, Ying Wang, Wenzhong Xing, Xiumei Xu & Rui Wu. (2023) Comparison of the efficacy and safety of first-line treatments for of advanced EGFR mutation-positive non-small-cell lung cancer in Asian populations: a systematic review and network meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
L.E. Hendriks, K.M. Kerr, J. Menis, T.S. Mok, U. Nestle, A. Passaro, S. Peters, D. Planchard, E.F. Smit, B.J. Solomon, G. Veronesi & M. Reck. (2023) Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 34:4, pages 339-357.
Crossref
Crossref
Laurent Greillier, Manon Gauvrit, Elena Paillaud, Nicolas Girard, Coline Montégut, Rabia Boulahssass, Marie Wislez, Frédéric Pamoukdjian, Romain Corre, Mathilde Cabart, Philippe Caillet, Yaniss Belaroussi, Matthieu Frasca, Pernelle Noize, Pascal Wang, Soraya Mebarki, Simone Mathoulin-Pelissier & Anne-Laure Couderc. (2022) Targeted Therapy for Older Patients with Non-Small Cell Lung Cancer: Systematic Review and Guidelines from the French Society of Geriatric Oncology (SoFOG) and the French-Language Society of Pulmonology (SPLF)/French-Language Oncology Group (GOLF). Cancers 14:3, pages 769.
Crossref
Crossref
Xin Nie, Ping Zhang, Gang Cheng, Xiao‐Nan Wu & Lin Li. (2021) Survival analysis for older patients with epidermal growth factor receptor mutation‐positive advanced non‐small cell lung cancer after progression of first‐line gefitinib. Asia-Pacific Journal of Clinical Oncology 18:1, pages 150-155.
Crossref
Crossref
Masamichi Mineshita, Kei Morikawa, Naoki Furuya, Hirotaka Kida, Hiroki Nishine, Hiroshi Handa & Takeo Inoue. (2021) Flexible bronchoscopy for lung cancer diagnosis in patients aged ≥85 years. Geriatrics & Gerontology International 22:1, pages 32-35.
Crossref
Crossref
Fabio Gomes, Kathryn Banfill, Andrea Bille, Stephanie Fraser & Giuseppe Banna. 2022. Frailty in Older Adults with Cancer. Frailty in Older Adults with Cancer
319
339
.
Yuji Minegishi, Ou Yamaguchi, Shunichi Sugawara, Shoichi Kuyama, Satoshi Watanabe, Kazuhiro Usui, Masahide Mori, Osamu Hataji, Toshihiro Nukiwa, Satoshi Morita, Kunihiko Kobayashi & Akihiko Gemma. (2021) A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027. BMC Cancer 21:1.
Crossref
Crossref
Gaku Yamamoto, Hajime Asahina, Osamu Honjo, Toshiyuki Sumi, Atsushi Nakamura, Kenichiro Ito, Hajime Kikuchi, Fumihiro Hommura, Ryoichi Honda, Keiki Yokoo, Yuka Fujita, Satoshi Oizumi, Ryo Morita, Yasuyuki Ikezawa, Hisashi Tanaka, Nozomu Kimura, Takaaki Sasaki, Noriaki Sukoh, Taichi Takashina, Toshiyuki Harada, Hirotoshi Dosaka-Akita, Hiroshi Isobe, Gaku Yamamoto, Hajime Asahina, Osamu Honjo, Toshiyuki Sumi, Atsushi Nakamura, Kenichiro Ito, Hiroshi Isobe, Hajime Kikuchi, Fumihiro Hommura, Ryoichi Honda, Keiki Yokoo, Yuka Fujita, Satoshi Oizumi, Ryo Morita, Yasuyuki Ikezawa, Hisashi Tanaka, Nozomu Kimura, Takaaki Sasaki, Noriaki Sukoh, Taichi Takashina, Toshiyuki Harada & Hirotoshi Akita. (2021) First-line osimertinib in elderly patients with epidermal growth factor receptor-mutated advanced non-small cell lung cancer: a retrospective multicenter study (HOT2002). Scientific Reports 11:1.
Crossref
Crossref
Jonathan Pham, Matthew Conron, Gavin Wright, Paul Mitchell, David Ball, Jennifer Philip, Margaret Brand, John Zalcberg & Rob G. Stirling. (2021) Excess mortality and undertreatment in elderly lung cancer patients: treatment nihilism in the modern era?. ERJ Open Research 7:2, pages 00393-2020.
Crossref
Crossref
Akihiro Yoshimura, Yusuke Chihara, Koji Date, Nobuyo Tamiya, Yoshizumi Takemura, Tatsuya Imabayashi, Yoshiko Kaneko, Tadaaki Yamada, Mikio Ueda, Taichiro Arimoto, Junji Uchino, Yoshinobu Iwasaki & Koichi Takayama. (2019) A Phase II Study of S-1 and Paclitaxel Combination Therapy as a First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer. The Oncologist 24:4, pages 459-e131.
Crossref
Crossref
Zorawar S. Noor & Jonathan W. Goldman. 2019. Targeted Therapies for Lung Cancer. Targeted Therapies for Lung Cancer
1
30
.
Hisao Imai, Kyoichi Kaira, Kensuke Suzuki, Masaki Anzai, Takeshi Tsuda, Tamotsu Ishizuka, Tomohito Kuwako, Ichiro Naruse, Kenji Nemoto, Junji Uchino, Nobutoshi Morozumi, Shinichi Ishihara, Koichi Minato & Takeshi Hisada. (2018) A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations. Lung Cancer 126, pages 41-47.
Crossref
Crossref
Paul A. BunnJrJr & Anastasios Dimou. (2018) Systemic Therapy for Elderly Patients With Advanced Non–Small-Cell Lung Cancers. Journal of Clinical Oncology 36:25, pages 2571-2574.
Crossref
Crossref
Juliet Carmichael, Daisy Wing-san Mak & Mary O’Brien. (2018) A Review of Recent Advances in the Treatment of Elderly and Poor Performance NSCLC. Cancers 10:7, pages 236.
Crossref
Crossref
Qingming Shi, Maojing Guan, Yong Wang, Congjing Xu, Lei Tang, Wenhua Fu, Minghong Bi, Xiang Sun, Kangsheng Gu & Dongsheng Pang. (2018) Survival analysis of patients with advanced non-small cell lung cancer receiving tyrosine kinase inhibitor (TKI) treatment: A multi-center retrospective study. Thoracic Cancer 9:2, pages 278-283.
Crossref
Crossref
Nakano Takayuki, Tanimura Keiko, Uchino Junji, Kaneko Yoshiko, Tamiya Nobuyo, Yamada Tadaaki & Takayama Koichi. (2018) Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management. BioMed Research International 2018, pages 1-8.
Crossref
Crossref
Oscar Juan & Sanjay Popat. (2017) Treatment choice in epidermal growth factor receptor mutation-positive non-small cell lung carcinoma: latest evidence and clinical implications. Therapeutic Advances in Medical Oncology 9:3, pages 201-216.
Crossref
Crossref
Satoshi IKEDA, Chigusa NAGATA & Keiko SUZUKI. (2016) Problem in Epidermal Growth Factor Receptor Gene Mutation Detection Using Trans-Bronchial Lung Biopsy Samples. JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE 64:6, pages 1028-1034.
Crossref
Crossref
Gabriele Minuti, Armida D’Incecco & Federico Cappuzzo. (2015) Current and Emerging Options in the Management of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Considerations in the Elderly. Drugs & Aging 32:11, pages 907-916.
Crossref
Crossref